Polycythemia Vera clinical trials at University of California Health
2 in progress, 1 open to eligible people
Showing trials for
A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera
open to eligible people ages 18 years and up
The study is designed to evaluate the safety and efficacy of rusfertide in subjects with polycythemia vera (PV) in maintaining hematocrit control and in improving symptoms of PV.
at UCLA UCSD UCSF
An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms
Sorry, in progress, not accepting new patients
This is a phase I/II study evaluating the optimal dose of N-acetylcysteine (N-AC) in patients with myeloproliferative neoplasms (MPN).
at UC Irvine
Our lead scientists for Polycythemia Vera research studies include Angela G. Fleischman.